Biofrontera Inc. (BFRI) stock
BFRINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/30
$0.59+0.02 (+4.09%)
Close on Nov 17, 2026Market cap $8.81MP/E –Yield –
Biofrontera pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for Biofrontera
Biofrontera has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?